Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 847513357 | 8475133 | 57 | F | 20111012 | 20160708 | 20120323 | 20160719 | EXP | PHHY2011CA89823 | SANDOZ | 67.22 | YR | M | Y | 0.00000 | 20160719 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 847513357 | 8475133 | 1 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK UG, ONCE/SINGLE | 0 | 1X | |||||||||
| 847513357 | 8475133 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, BIW (EVERY 2 WEEKS) | U | 0 | 40 | MG | QOW | ||||||
| 847513357 | 8475133 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, BIW EVERY 2 WEEKS | U | 0 | 20 | MG | QOW | ||||||
| 847513357 | 8475133 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, BIW EVERY 2 WEEKS | U | 0 | 30 | MG | QOW | ||||||
| 847513357 | 8475133 | 5 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG | U | 0 | 30 | MG | |||||||
| 847513357 | 8475133 | 6 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, BIW (EVERY 2 WEEKS) | U | 0 | 40 | MG | QOW | ||||||
| 847513357 | 8475133 | 7 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 60 MG, BIW (EVERY 2 WEEKS) | U | 0 | 60 | MG | QOW | ||||||
| 847513357 | 8475133 | 8 | PS | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG, BID | Y | 73288 | 50 | MG | BID | ||||||
| 847513357 | 8475133 | 9 | SS | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, BID | Y | 73288 | 25 | MG | BID | ||||||
| 847513357 | 8475133 | 10 | SS | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, QD | Y | 73288 | 25 | MG | QD | ||||||
| 847513357 | 8475133 | 11 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | QHS | 0 | ||||||||||
| 847513357 | 8475133 | 12 | C | NOVORAPID | INSULIN ASPART | 1 | Subcutaneous | QD (4 TO 5 TIMES A DAY) | U | 0 | |||||||||
| 847513357 | 8475133 | 13 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | UNK | U | 0 | |||||||||
| 847513357 | 8475133 | 14 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 847513357 | 8475133 | 15 | C | ASAPHEN | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 847513357 | 8475133 | 16 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 847513357 | 8475133 | 17 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Unknown | U | 0 | ||||||||||
| 847513357 | 8475133 | 18 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 847513357 | 8475133 | 1 | Carcinoid syndrome |
| 847513357 | 8475133 | 2 | Carcinoid syndrome |
| 847513357 | 8475133 | 8 | Product used for unknown indication |
| 847513357 | 8475133 | 11 | Product used for unknown indication |
| 847513357 | 8475133 | 12 | Product used for unknown indication |
| 847513357 | 8475133 | 13 | Product used for unknown indication |
| 847513357 | 8475133 | 14 | Product used for unknown indication |
| 847513357 | 8475133 | 15 | Product used for unknown indication |
| 847513357 | 8475133 | 16 | Product used for unknown indication |
| 847513357 | 8475133 | 17 | Product used for unknown indication |
| 847513357 | 8475133 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 847513357 | 8475133 | OT |
| 847513357 | 8475133 | LT |
| 847513357 | 8475133 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 847513357 | 8475133 | 5-hydroxyindolacetic acid in urine increased | |
| 847513357 | 8475133 | Abdominal discomfort | |
| 847513357 | 8475133 | Abdominal distension | |
| 847513357 | 8475133 | Abdominal mass | |
| 847513357 | 8475133 | Abdominal pain | |
| 847513357 | 8475133 | Abdominal pain upper | |
| 847513357 | 8475133 | Arthralgia | |
| 847513357 | 8475133 | Asthenia | |
| 847513357 | 8475133 | Blood chromogranin A increased | |
| 847513357 | 8475133 | Blood glucose decreased | |
| 847513357 | 8475133 | Blood glucose fluctuation | |
| 847513357 | 8475133 | Blood pressure diastolic decreased | |
| 847513357 | 8475133 | Blood pressure systolic increased | |
| 847513357 | 8475133 | Diabetes mellitus | |
| 847513357 | 8475133 | Diarrhoea | |
| 847513357 | 8475133 | Discomfort | |
| 847513357 | 8475133 | Disorientation | |
| 847513357 | 8475133 | Dyspnoea | |
| 847513357 | 8475133 | Fatigue | |
| 847513357 | 8475133 | Feeling abnormal | |
| 847513357 | 8475133 | Flushing | |
| 847513357 | 8475133 | Frequent bowel movements | |
| 847513357 | 8475133 | Gait disturbance | |
| 847513357 | 8475133 | Gastrointestinal hypomotility | |
| 847513357 | 8475133 | Heart rate decreased | |
| 847513357 | 8475133 | Hyperhidrosis | |
| 847513357 | 8475133 | Hypotension | |
| 847513357 | 8475133 | Inappropriate schedule of drug administration | |
| 847513357 | 8475133 | Incorrect dose administered | |
| 847513357 | 8475133 | Injection site bruising | |
| 847513357 | 8475133 | Injection site discomfort | |
| 847513357 | 8475133 | Injection site mass | |
| 847513357 | 8475133 | Injection site pain | |
| 847513357 | 8475133 | Injection site scar | |
| 847513357 | 8475133 | Macular degeneration | |
| 847513357 | 8475133 | Malignant neoplasm progression | |
| 847513357 | 8475133 | Nausea | |
| 847513357 | 8475133 | Needle issue | |
| 847513357 | 8475133 | Oncologic complication | |
| 847513357 | 8475133 | Sleep disorder | |
| 847513357 | 8475133 | Syncope | |
| 847513357 | 8475133 | Therapeutic response decreased | |
| 847513357 | 8475133 | Underdose | |
| 847513357 | 8475133 | Visual acuity reduced | |
| 847513357 | 8475133 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 847513357 | 8475133 | 1 | 20110927 | 20110927 | 0 | |
| 847513357 | 8475133 | 2 | 20111012 | 0 | ||
| 847513357 | 8475133 | 4 | 20110927 | 0 | ||
| 847513357 | 8475133 | 5 | 20140606 | 0 |